Skip to content

Clinical trials

Observational Cognitive Dysfunction trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Observational Country / region: Canada Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20071
20101
20111
20121
20131
20143
20165
20175
20182
20191
20204
20213
20226
20235
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Unknown status11
Recruiting8
Active, not recruiting4
Enrolling by invitation2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sunnybrook Health Sciences Centre5
University Health Network, Toronto5
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
University of Southern California3
Alzheimer's Disease Cooperative Study (ADCS)2
Centre for Addiction and Mental Health2
Dr. Gordon Boyd2
Jewish General Hospital2
University of Alberta2
University of British Columbia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction49
Alzheimer Disease21
Dementia16
Delirium5
Plaque, Amyloid5
Cognition Disorders4
Memory Disorders4
Parkinson Disease4
Ischemic Attack, Transient3
Lewy Body Disease3

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.